Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-10-07

AUTHORS

Amayelle Rey, Valérie Gras-Champel, Thibaut Balcaen, Gabriel Choukroun, Kamel Masmoudi, Sophie Liabeuf

ABSTRACT

BackgroundAcute kidney injury (AKI) has serious short- and long-term consequences. The objective of the present study of a cohort of hospitalized patients with AKI was to (i) evaluate the proportion of patients with hospital-acquired (HA) AKI and community-acquired (CA) AKI, the characteristics of these patients and the AKIs, and the short-term outcomes, and (ii) determine the performance of several ICD-10 codes for identifying AKI (both CA and HA) and drug-induced AKI.MethodsA cohort of hospitalized patients with AKI was constituted by screening hospital’s electronic medical records (EMRs) for cases of AKI. We distinguished between and compared CA–AKI and HA–AKI and evaluated the proportion of AKIs that were drug-induced. The EMR data were merged with hospital billing codes (according to the International Classification of Diseases, 10th Edition (ICD-10)) for each hospital stay. The ability of ICD-10 codes to identify AKIs (depending on the type of injury) was determined by calculating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Lastly, we sought to validate specific ICD-10 codes for drug-induced AKI.ResultsOf the 2473 patients included, 1557 experienced an AKI (HA–AKI: 59.3%; CA–AKI: 40.7%). Patients with CA–AKI had a better short-term outcome and a lower death rate (7.6%, vs. 20% for HA–AKI). One AKI in three was drug-induced. The combination of AKI codes had a very high specificity (94.8%), a high PPV (94.9%), a moderate NPV (56.7%) and moderate sensitivity (57.4%). The sensitivity was higher for CA–AKI (72.2%, vs. 47.2% for HA–AKI), for more severe AKI (82.8% for grade 3 AKI vs. 43.7% for grade 1 AKI), and for patients with CKD. Use of a specific ICD-10 code for drug-induced AKI (N14x) alone gave a very low sensitivity (1.8%), whereas combining codes for adverse drug reactions with AKI-specific codes increased the sensitivity.ConclusionOur results show that the combination of an EMR-based analysis with ICD-10-based hospital billing codes gives a comprehensive “real-life” picture of AKI in hospital settings. We expect that this approach will enable researchers to study AKI in more depth. More... »

PAGES

1-14

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40620-021-01174-z

DOI

http://dx.doi.org/10.1007/s40620-021-01174-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141694847

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34618334


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.11162.35", 
          "name": [
            "Division of Clinical Pharmacology, Amiens University Hospital, Avenue Ren\u00e9 Laennec, 80000, Amiens, France", 
            "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rey", 
        "givenName": "Amayelle", 
        "id": "sg:person.011264446527.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011264446527.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.11162.35", 
          "name": [
            "Division of Clinical Pharmacology, Amiens University Hospital, Avenue Ren\u00e9 Laennec, 80000, Amiens, France", 
            "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gras-Champel", 
        "givenName": "Val\u00e9rie", 
        "id": "sg:person.01142145121.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142145121.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Information Department, Amiens University Hospital, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.134996.0", 
          "name": [
            "Medical Information Department, Amiens University Hospital, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Balcaen", 
        "givenName": "Thibaut", 
        "id": "sg:person.0647426215.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647426215.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology, Amiens University Hospital, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.134996.0", 
          "name": [
            "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France", 
            "Division of Nephrology, Amiens University Hospital, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Choukroun", 
        "givenName": "Gabriel", 
        "id": "sg:person.01055726260.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055726260.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Pharmacology, Amiens University Hospital, Avenue Ren\u00e9 Laennec, 80000, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.134996.0", 
          "name": [
            "Division of Clinical Pharmacology, Amiens University Hospital, Avenue Ren\u00e9 Laennec, 80000, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masmoudi", 
        "givenName": "Kamel", 
        "id": "sg:person.01075202731.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075202731.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France", 
          "id": "http://www.grid.ac/institutes/grid.11162.35", 
          "name": [
            "Division of Clinical Pharmacology, Amiens University Hospital, Avenue Ren\u00e9 Laennec, 80000, Amiens, France", 
            "MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liabeuf", 
        "givenName": "Sophie", 
        "id": "sg:person.0720377060.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720377060.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12916-017-0890-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1087306188", 
          "https://doi.org/10.1186/s12916-017-0890-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneph.2013.282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004481347", 
          "https://doi.org/10.1038/nrneph.2013.282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6963-13-473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038789455", 
          "https://doi.org/10.1186/1472-6963-13-473"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-07", 
    "datePublishedReg": "2021-10-07", 
    "description": "BackgroundAcute kidney injury (AKI) has serious short- and long-term consequences. The objective of the present study of a cohort of hospitalized patients with AKI was to (i) evaluate the proportion of patients with hospital-acquired (HA) AKI and community-acquired (CA) AKI, the characteristics of these patients and the AKIs, and the short-term outcomes, and (ii) determine the performance of several ICD-10 codes for identifying AKI (both CA and HA) and drug-induced AKI.MethodsA cohort of hospitalized patients with AKI was constituted by screening hospital\u2019s electronic medical records (EMRs) for cases of AKI. We distinguished between and compared CA\u2013AKI and HA\u2013AKI and evaluated the proportion of AKIs that were drug-induced. The EMR data were merged with hospital billing codes (according to the International Classification of Diseases, 10th Edition (ICD-10)) for each hospital stay. The ability of ICD-10 codes to identify AKIs (depending on the type of injury) was determined by calculating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Lastly, we sought to validate specific ICD-10 codes for drug-induced AKI.ResultsOf the 2473 patients included, 1557 experienced an AKI (HA\u2013AKI: 59.3%; CA\u2013AKI: 40.7%). Patients with CA\u2013AKI had a better short-term outcome and a lower death rate (7.6%, vs. 20% for HA\u2013AKI). One AKI in three was drug-induced. The combination of AKI codes had a very high specificity (94.8%), a high PPV (94.9%), a moderate NPV (56.7%) and moderate sensitivity (57.4%). The sensitivity was higher for CA\u2013AKI (72.2%, vs. 47.2% for HA\u2013AKI), for more severe AKI (82.8% for grade 3 AKI vs. 43.7% for grade 1 AKI), and for patients with CKD. Use of a specific ICD-10 code for drug-induced AKI (N14x) alone gave a very low sensitivity (1.8%), whereas combining codes for adverse drug reactions with AKI-specific codes increased the sensitivity.ConclusionOur results show that the combination of an EMR-based analysis with ICD-10-based hospital billing codes gives a comprehensive \u201creal-life\u201d picture of AKI in hospital settings. We expect that this approach will enable researchers to study AKI in more depth.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40620-021-01174-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100597", 
        "issn": [
          "1121-8428", 
          "1724-6059"
        ], 
        "name": "Journal of Nephrology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "ICD-10 codes", 
      "electronic medical records", 
      "negative predictive value", 
      "positive predictive value", 
      "hospital billing codes", 
      "short-term outcomes", 
      "specific ICD-10 codes", 
      "CA-AKI", 
      "kidney injury", 
      "billing codes", 
      "predictive value", 
      "drug-induced acute kidney injury", 
      "better short-term outcomes", 
      "hospital-acquired AKI", 
      "community-acquired AKI", 
      "cases of AKI", 
      "moderate negative predictive value", 
      "BackgroundAcute kidney injury", 
      "acute kidney injury", 
      "proportion of patients", 
      "high positive predictive value", 
      "hospital electronic medical records", 
      "hospital administrative database", 
      "adverse drug reactions", 
      "lower death rates", 
      "HA-AKI", 
      "severe AKI", 
      "hospital stay", 
      "MethodsA cohort", 
      "drug reactions", 
      "medical records", 
      "administrative databases", 
      "long-term consequences", 
      "hospital setting", 
      "patients", 
      "AKI", 
      "death rate", 
      "ConclusionOur results", 
      "EMR data", 
      "moderate sensitivity", 
      "injury", 
      "cohort", 
      "present study", 
      "outcomes", 
      "low sensitivity", 
      "high specificity", 
      "CKD", 
      "stay", 
      "ResultsOf", 
      "specificity", 
      "proportion", 
      "sensitivity", 
      "setting", 
      "use", 
      "combination", 
      "records", 
      "study", 
      "cases", 
      "database", 
      "rate", 
      "objective", 
      "more depth", 
      "ability", 
      "values", 
      "data", 
      "consequences", 
      "analysis", 
      "results", 
      "characteristics", 
      "picture", 
      "reaction", 
      "approach", 
      "researchers", 
      "AKIS", 
      "code", 
      "depth", 
      "performance", 
      "drug-induced AKI", 
      "proportion of AKIs", 
      "AKI codes", 
      "AKI-specific codes", 
      "ICD-10-based hospital billing codes", 
      "picture of AKI"
    ], 
    "name": "Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury", 
    "pagination": "1-14", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141694847"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40620-021-01174-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34618334"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40620-021-01174-z", 
      "https://app.dimensions.ai/details/publication/pub.1141694847"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_891.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40620-021-01174-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40620-021-01174-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40620-021-01174-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40620-021-01174-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40620-021-01174-z'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      22 PREDICATES      110 URIs      99 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40620-021-01174-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Na65e622e04124931bfa36a4da6e36776
4 schema:citation sg:pub.10.1038/nrneph.2013.282
5 sg:pub.10.1186/1472-6963-13-473
6 sg:pub.10.1186/s12916-017-0890-9
7 schema:datePublished 2021-10-07
8 schema:datePublishedReg 2021-10-07
9 schema:description BackgroundAcute kidney injury (AKI) has serious short- and long-term consequences. The objective of the present study of a cohort of hospitalized patients with AKI was to (i) evaluate the proportion of patients with hospital-acquired (HA) AKI and community-acquired (CA) AKI, the characteristics of these patients and the AKIs, and the short-term outcomes, and (ii) determine the performance of several ICD-10 codes for identifying AKI (both CA and HA) and drug-induced AKI.MethodsA cohort of hospitalized patients with AKI was constituted by screening hospital’s electronic medical records (EMRs) for cases of AKI. We distinguished between and compared CA–AKI and HA–AKI and evaluated the proportion of AKIs that were drug-induced. The EMR data were merged with hospital billing codes (according to the International Classification of Diseases, 10th Edition (ICD-10)) for each hospital stay. The ability of ICD-10 codes to identify AKIs (depending on the type of injury) was determined by calculating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Lastly, we sought to validate specific ICD-10 codes for drug-induced AKI.ResultsOf the 2473 patients included, 1557 experienced an AKI (HA–AKI: 59.3%; CA–AKI: 40.7%). Patients with CA–AKI had a better short-term outcome and a lower death rate (7.6%, vs. 20% for HA–AKI). One AKI in three was drug-induced. The combination of AKI codes had a very high specificity (94.8%), a high PPV (94.9%), a moderate NPV (56.7%) and moderate sensitivity (57.4%). The sensitivity was higher for CA–AKI (72.2%, vs. 47.2% for HA–AKI), for more severe AKI (82.8% for grade 3 AKI vs. 43.7% for grade 1 AKI), and for patients with CKD. Use of a specific ICD-10 code for drug-induced AKI (N14x) alone gave a very low sensitivity (1.8%), whereas combining codes for adverse drug reactions with AKI-specific codes increased the sensitivity.ConclusionOur results show that the combination of an EMR-based analysis with ICD-10-based hospital billing codes gives a comprehensive “real-life” picture of AKI in hospital settings. We expect that this approach will enable researchers to study AKI in more depth.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree false
13 schema:isPartOf sg:journal.1100597
14 schema:keywords AKI
15 AKI codes
16 AKI-specific codes
17 AKIS
18 BackgroundAcute kidney injury
19 CA-AKI
20 CKD
21 ConclusionOur results
22 EMR data
23 HA-AKI
24 ICD-10 codes
25 ICD-10-based hospital billing codes
26 MethodsA cohort
27 ResultsOf
28 ability
29 acute kidney injury
30 administrative databases
31 adverse drug reactions
32 analysis
33 approach
34 better short-term outcomes
35 billing codes
36 cases
37 cases of AKI
38 characteristics
39 code
40 cohort
41 combination
42 community-acquired AKI
43 consequences
44 data
45 database
46 death rate
47 depth
48 drug reactions
49 drug-induced AKI
50 drug-induced acute kidney injury
51 electronic medical records
52 high positive predictive value
53 high specificity
54 hospital administrative database
55 hospital billing codes
56 hospital electronic medical records
57 hospital setting
58 hospital stay
59 hospital-acquired AKI
60 injury
61 kidney injury
62 long-term consequences
63 low sensitivity
64 lower death rates
65 medical records
66 moderate negative predictive value
67 moderate sensitivity
68 more depth
69 negative predictive value
70 objective
71 outcomes
72 patients
73 performance
74 picture
75 picture of AKI
76 positive predictive value
77 predictive value
78 present study
79 proportion
80 proportion of AKIs
81 proportion of patients
82 rate
83 reaction
84 records
85 researchers
86 results
87 sensitivity
88 setting
89 severe AKI
90 short-term outcomes
91 specific ICD-10 codes
92 specificity
93 stay
94 study
95 use
96 values
97 schema:name Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury
98 schema:pagination 1-14
99 schema:productId N4fac0aa05b334fd2b23d570deffdb8f8
100 Nfac59ef2543c416d98bd143702e8f88e
101 Nfb667358134b4f3fb42adea44e972106
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141694847
103 https://doi.org/10.1007/s40620-021-01174-z
104 schema:sdDatePublished 2022-01-01T19:02
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher Nd0f6769837a9406fa584dc46bb42f91a
107 schema:url https://doi.org/10.1007/s40620-021-01174-z
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N38dc45f2e3f04df9936556e2c3a01f5b rdf:first sg:person.01142145121.01
112 rdf:rest Nb4df36450e8b442fa01336226a0b91da
113 N4fac0aa05b334fd2b23d570deffdb8f8 schema:name doi
114 schema:value 10.1007/s40620-021-01174-z
115 rdf:type schema:PropertyValue
116 N73533d81c33a41428067510d19c81f06 rdf:first sg:person.0720377060.54
117 rdf:rest rdf:nil
118 N9fd66957642c4fd694d5f2224add78da rdf:first sg:person.01055726260.16
119 rdf:rest Nbe1c3ef7a78e4c4e95eabe8fc4ce20d1
120 Na65e622e04124931bfa36a4da6e36776 rdf:first sg:person.011264446527.08
121 rdf:rest N38dc45f2e3f04df9936556e2c3a01f5b
122 Nb4df36450e8b442fa01336226a0b91da rdf:first sg:person.0647426215.98
123 rdf:rest N9fd66957642c4fd694d5f2224add78da
124 Nbe1c3ef7a78e4c4e95eabe8fc4ce20d1 rdf:first sg:person.01075202731.17
125 rdf:rest N73533d81c33a41428067510d19c81f06
126 Nd0f6769837a9406fa584dc46bb42f91a schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 Nfac59ef2543c416d98bd143702e8f88e schema:name pubmed_id
129 schema:value 34618334
130 rdf:type schema:PropertyValue
131 Nfb667358134b4f3fb42adea44e972106 schema:name dimensions_id
132 schema:value pub.1141694847
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
138 schema:name Clinical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1100597 schema:issn 1121-8428
141 1724-6059
142 schema:name Journal of Nephrology
143 schema:publisher Springer Nature
144 rdf:type schema:Periodical
145 sg:person.01055726260.16 schema:affiliation grid-institutes:grid.134996.0
146 schema:familyName Choukroun
147 schema:givenName Gabriel
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055726260.16
149 rdf:type schema:Person
150 sg:person.01075202731.17 schema:affiliation grid-institutes:grid.134996.0
151 schema:familyName Masmoudi
152 schema:givenName Kamel
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075202731.17
154 rdf:type schema:Person
155 sg:person.011264446527.08 schema:affiliation grid-institutes:grid.11162.35
156 schema:familyName Rey
157 schema:givenName Amayelle
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011264446527.08
159 rdf:type schema:Person
160 sg:person.01142145121.01 schema:affiliation grid-institutes:grid.11162.35
161 schema:familyName Gras-Champel
162 schema:givenName Valérie
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142145121.01
164 rdf:type schema:Person
165 sg:person.0647426215.98 schema:affiliation grid-institutes:grid.134996.0
166 schema:familyName Balcaen
167 schema:givenName Thibaut
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647426215.98
169 rdf:type schema:Person
170 sg:person.0720377060.54 schema:affiliation grid-institutes:grid.11162.35
171 schema:familyName Liabeuf
172 schema:givenName Sophie
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720377060.54
174 rdf:type schema:Person
175 sg:pub.10.1038/nrneph.2013.282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004481347
176 https://doi.org/10.1038/nrneph.2013.282
177 rdf:type schema:CreativeWork
178 sg:pub.10.1186/1472-6963-13-473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038789455
179 https://doi.org/10.1186/1472-6963-13-473
180 rdf:type schema:CreativeWork
181 sg:pub.10.1186/s12916-017-0890-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1087306188
182 https://doi.org/10.1186/s12916-017-0890-9
183 rdf:type schema:CreativeWork
184 grid-institutes:grid.11162.35 schema:alternateName MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France
185 schema:name Division of Clinical Pharmacology, Amiens University Hospital, Avenue René Laennec, 80000, Amiens, France
186 MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France
187 rdf:type schema:Organization
188 grid-institutes:grid.134996.0 schema:alternateName Division of Clinical Pharmacology, Amiens University Hospital, Avenue René Laennec, 80000, Amiens, France
189 Division of Nephrology, Amiens University Hospital, Amiens, France
190 Medical Information Department, Amiens University Hospital, Amiens, France
191 schema:name Division of Clinical Pharmacology, Amiens University Hospital, Avenue René Laennec, 80000, Amiens, France
192 Division of Nephrology, Amiens University Hospital, Amiens, France
193 MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France
194 Medical Information Department, Amiens University Hospital, Amiens, France
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...